Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Glucocorticoid hormone-induced chromatin remodeling enhances human hematopoietic stem cell homing and engraftment

Abstract

Efficient hematopoietic stem cell (HSC) homing is important for hematopoietic cell transplantation (HCT), especially when HSC numbers are limited, as in the use of cord blood (CB). In a screen of small-molecule compounds, we identified glucocorticoid (GC) hormone signaling as an activator of CXCR4 expression in human CB HSCs and hematopoietic progenitor cells (HPCs). Short-term GC pretreatment of human CB HSCs and HPCs promoted SDF-1–CXCR4-axis-mediated chemotaxis, homing, and long-term engraftment when these cells were transplanted into primary- and secondary-recipient NSG mice. Mechanistically, activated glucocorticoid receptor binds directly to a glucocorticoid response element in the CXCR4 promoter and recruits the SRC-1–p300 complex to promote H4K5 and H4K16 histone acetylation, facilitating transcription of CXCR4. These results suggest a new and readily available means to enhance the clinical efficacy of CB HCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Glucocorticoids increase cell surface expression of CXCR4 and promote chemotaxis mediated by the SDF-1–CXCR4 axis, homing, and long-term engraftment of human hematopoietic stem and progenitor cells.
Figure 2: Glucocorticoids enhance H4K5 and H4K16 acetylation associated with the CXCR4 promoter, facilitate expression of CXCR4, and promote homing of human CB CD34+ cells.

Similar content being viewed by others

References

  1. Doulatov, S., Notta, F., Laurenti, E. & Dick, J.E. Cell Stem Cell 10, 120–136 (2012).

    Article  CAS  Google Scholar 

  2. Ballen, K.K., Gluckman, E. & Broxmeyer, H.E. Blood 122, 491–498 (2013).

    Article  CAS  Google Scholar 

  3. Fares, I. et al. Science 345, 1509–1512 (2014).

    Article  CAS  Google Scholar 

  4. Boitano, A.E. et al. Science 329, 1345–1348 (2010).

    Article  CAS  Google Scholar 

  5. Wagner, J.E. Jr. et al. Cell Stem Cell 18, 144–155 (2016).

    Article  CAS  Google Scholar 

  6. Morrison, S.J. & Scadden, D.T. Nature 505, 327–334 (2014).

    Article  CAS  Google Scholar 

  7. Peled, A. et al. Science 283, 845–848 (1999).

    Article  CAS  Google Scholar 

  8. Capitano, M.L. & Broxmeyer, H.E. Encyclopedia of Cell Biology 3, 624–631 (2016).

    Article  Google Scholar 

  9. Christopherson, K.W., II, Hangoc, G., Mantel, C.R. & Broxmeyer, H.E. Science 305, 1000–1003 (2004).

    Article  CAS  Google Scholar 

  10. Hoggatt, J., Singh, P., Sampath, J. & Pelus, L.M. Blood 113, 5444–5455 (2009).

    Article  CAS  Google Scholar 

  11. Chaurasia, P., Gajzer, D.C., Schaniel, C., D'Souza, S. & Hoffman, R. J. Clin. Invest. 124, 2378–2395 (2014).

    Article  CAS  Google Scholar 

  12. Gul, H. et al. Stem Cells Dev. 18, 831–838 (2009).

    Article  CAS  Google Scholar 

  13. Capitano, M.L., Hangoc, G., Cooper, S. & Broxmeyer, H.E. Stem Cells 33, 1975–1984 (2015).

    Article  CAS  Google Scholar 

  14. Högger, P. & Rohdewald, P. Steroids 59, 597–602 (1994).

    Article  Google Scholar 

  15. Broxmeyer, H.E. et al. J. Exp. Med. 201, 1307–1318 (2005).

    Article  CAS  Google Scholar 

  16. Kadmiel, M. & Cidlowski, J.A. Trends Pharmacol. Sci. 34, 518–530 (2013).

    Article  CAS  Google Scholar 

  17. Watson, L.C. et al. Nat. Struct. Mol. Biol. 20, 876–883 (2013).

    Article  CAS  Google Scholar 

  18. McKenna, N.J. & O'Malley, B.W. Cell 108, 465–474 (2002).

    Article  CAS  Google Scholar 

  19. Lonard, D.M. & O'malley, B.W. Mol. Cell 27, 691–700 (2007).

    Article  CAS  Google Scholar 

  20. Eberharter, A. & Becker, P.B. EMBO Rep. 3, 224–229 (2002).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank other members in the Broxmeyer laboratory for helpful discussion and assistance and A.L. Sinn from the In vivo Therapeutics Core of the Indiana University School of Medicine for transplantation assistance. This work was supported by US Public Health Service Grants from the NIH to H.E.B. (R01 HL112669, R01 HL056416, U54 DK106846).

Author information

Authors and Affiliations

Authors

Contributions

B.G. and H.E.B. conceived the research, designed and performed experiments, interpreted data, and wrote the manuscript. X.H. and S.C. performed intravenous injection and interpreted data.

Corresponding author

Correspondence to Hal E Broxmeyer.

Ethics declarations

Competing interests

H.E.B. is a member of the Medical Scientific Advisory Board of CordUse, a cord blood banking company based in Orlando, Florida.

Supplementary information

Supplementary Figures and Tables

Supplementary Figures 1–4 and Supplementary Tables 1–3 (PDF 3290 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, B., Huang, X., Cooper, S. et al. Glucocorticoid hormone-induced chromatin remodeling enhances human hematopoietic stem cell homing and engraftment. Nat Med 23, 424–428 (2017). https://doi.org/10.1038/nm.4298

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.4298

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing